Clinical trial · Interventional
Autonomic Involvement in Patient With Cognitive Decline
Evaluation of the Prevalence of Autonomic Nervous System Involvement in Patients With Cognitive Impairment by a Non-invasive Combined Study of Dysautonomia
NCT06292741CI-TRIAL-00125446recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective interventional study with a device for comparing autonomic parameters among patients with different forms of cognitive decline
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dementia, Mild | — | UNRESOLVED | — |
| Dementia of Alzheimer Type | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sudoscan | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- cognitive decline
- description
- comparison of autonomic parameters among subjects with different forms of cognitive decline
- interventionNames
- Device: Sudoscan
Primary outcomes (1)
- measure
- evaluation of the prevalence in autonomic dysfunction in patients with MCI and dementia
- timeFrame
- baseline through study completion, an average of 3 year
- description
- evaluation of the prevalence in autonomic dysfunction in patients with MCI and dementia
Secondary outcomes (2)
- measure
- correlation between the extent of autonomic involvement and the severity of cognitive decline
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * male and females between 50 and 85 years * cognitive decline (dementia, lewy's body dementia, Parkinson dementia, Alzheimer dementia) * mild cognitive decline ( lewy's body MCI, Parkinson MCI and Alzheimer MCI) * Ability to assume the upright position Exclusion Criteria: * diabetes mellitus * eye problems * severe cognitive decline * heart disease * peripheral neuropathy * language barrier * oncological disease * medical pathologies associated with cognitive deficits
References
Publications (0)
Data not yet available
No reference posted for this study.